- Home
- GDTC vs TOI Comparison
GDTC vs TOI Comparison
Compare GDTC & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDTC
- TOI
- Stock Information
- Founded
- GDTC 2018
- TOI 2007
- Country
- GDTC Singapore
- TOI United States
- Employees
- GDTC N/A
- TOI N/A
- Industry
- GDTC Biotechnology: Pharmaceutical Preparations
- TOI Medical/Nursing Services
- Sector
- GDTC Health Care
- TOI Health Care
- Exchange
- GDTC Nasdaq
- TOI Nasdaq
- Market Cap
- GDTC 23.7M
- TOI 22.7M
- IPO Year
- GDTC 2023
- TOI N/A
- Fundamental
- Price
- GDTC $2.13
- TOI $0.34
- Analyst Decision
- GDTC Buy
- TOI Strong Buy
- Analyst Count
- GDTC 1
- TOI 1
- Target Price
- GDTC $5.00
- TOI $2.50
- AVG Volume (30 Days)
- GDTC 12.4K
- TOI 54.1K
- Earning Date
- GDTC 01-01-0001
- TOI 11-06-2024
- Dividend Yield
- GDTC N/A
- TOI N/A
- EPS Growth
- GDTC N/A
- TOI N/A
- EPS
- GDTC N/A
- TOI N/A
- Revenue
- GDTC $330,254.00
- TOI $361,067,000.00
- Revenue This Year
- GDTC $4.46
- TOI $29.17
- Revenue Next Year
- GDTC N/A
- TOI $16.43
- P/E Ratio
- GDTC N/A
- TOI N/A
- Revenue Growth
- GDTC N/A
- TOI 23.31
- 52 Week Low
- GDTC $1.20
- TOI $0.27
- 52 Week High
- GDTC $5.50
- TOI $2.66
- Technical
- Relative Strength Index (RSI)
- GDTC 69.51
- TOI 55.99
- Support Level
- GDTC $1.96
- TOI $0.31
- Resistance Level
- GDTC $2.16
- TOI $0.33
- Average True Range (ATR)
- GDTC 0.15
- TOI 0.02
- MACD
- GDTC 0.03
- TOI 0.01
- Stochastic Oscillator
- GDTC 84.07
- TOI 53.16
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About TOI The Oncology Institute Inc.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services.